Pepgen Inc
Clinical trials sponsored by Pepgen Inc, explained in plain language.
-
Hope for DM1: Long-Term safety trial launches for experimental drug
Disease control Recruiting nowThis study looks at the long-term safety of an experimental drug called PGN-EDODM1 for people with myotonic dystrophy type 1 (DM1). It is for those who have already taken the drug in a previous study. About 48 adults will take part, and researchers will track any side effects ove…
Phase: PHASE2 • Sponsor: PepGen Inc • Aim: Disease control
Last updated May 17, 2026 11:50 UTC
-
New drug trial aims to tame muscle stiffness in rare disease
Disease control Recruiting nowThis study tests an experimental drug called PGN-EDODM1 in 24 adults with myotonic dystrophy type 1 (DM1), a condition that causes muscle stiffness and weakness. The main goal is to see if the drug is safe and tolerable compared to a placebo. Researchers will also measure how the…
Phase: PHASE2 • Sponsor: PepGen Inc • Aim: Disease control
Last updated May 06, 2026 16:03 UTC